These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6022834)

  • 1. Chloramphenicol, protein synthesis, and the metabolism of the carcinogen N-2-fluorenyldiacetamide in rats. Inhibition by chloramphenicol of carcinogen binding.
    Weisburger JH; Shirasu Y; Grantham PH; Weisburger EK
    J Biol Chem; 1967 Feb; 242(3):372-8. PubMed ID: 6022834
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of continuously fed 14C-labeled N-hydroxy-N-2-fluorenylacetamide at various intervals: effect of pituitary hormones.
    Shirasu Y; Grantham PH; Weisburger EK; Weisburger JH
    Cancer Res; 1967 May; 27(5):865-72. PubMed ID: 4290554
    [No Abstract]   [Full Text] [Related]  

  • 3. The carinogenicity of N-hydroxy-N-2-fluorenyl-acetamide and the matabolism of N-2-fluorenyl-acetamide in Praomis (mastomys) natalensis.
    Yamamoto RS; Pai SR; Korzis J; Weisburger JH
    Br J Cancer; 1968 Dec; 22(4):769-75. PubMed ID: 4303104
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism of the carcinogen N-2-fluorenylacetamide in germ-free and conventional rats.
    Grantham PH; Horton RE; Weisburger EK; Weisburger JH
    Biochem Pharmacol; 1970 Jan; 19(1):163-71. PubMed ID: 5507634
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolism of the carcinogen N-hydroxy-N-2-fluorenylacetamide in germ-free rats.
    Weisburger JH; Grantham PH; Horton RE; Weisburger EK
    Biochem Pharmacol; 1970 Jan; 19(1):151-62. PubMed ID: 5507633
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of N-2-fluorenyldiacetamide induced hepatic carcinogenesis in rats by chloramphenicol: a dose-related phenomenon with reduced protein binding of carcinogen.
    Oster WF; Firminger HI; Morrison DM
    Yale J Biol Med; 1971; 43(4-5):297-306. PubMed ID: 4325376
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of various inhibitors on nuclear protein synthesis in rat liver.
    Kuehl L
    J Cell Biol; 1969 May; 41(2):660-3. PubMed ID: 5783883
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on the biogenesis of mitochondrial protein components in rat liver slices.
    Beattie DS
    J Biol Chem; 1968 Aug; 243(15):4027-33. PubMed ID: 5666945
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of inhibition of mitochondrial protein synthesis in vitro upon thyroxine stimulation of oxygen consumption.
    Buchanan JL; Primack MP; Tapley DF
    Endocrinology; 1971 Aug; 89(2):534-7. PubMed ID: 5558001
    [No Abstract]   [Full Text] [Related]  

  • 10. Persistent binding of a new reaction product of the carcinogen N-hydroxy-N-2-acetylaminofluorene with guanine in rat liver DNA in vivo.
    Kriek E
    Cancer Res; 1972 Oct; 32(10):2042-8. PubMed ID: 5080759
    [No Abstract]   [Full Text] [Related]  

  • 11. In vivo incorporation of (1- 14 C)leucine into rat liver and serum protein after dietary supplementation with 3'-methyl-4-dimethylaminoazobenzene, chloramphenicol or both compounds.
    Blunck JM; Madsen NP
    Chem Biol Interact; 1972 Jan; 4(2):103-12. PubMed ID: 4621665
    [No Abstract]   [Full Text] [Related]  

  • 12. The conversion of the carcinogen N-hydroxy-2-fluorenylacetamide to o-amidophenols by rat liver in vitro. An inducible enzymatic reaction.
    Gutmann HR; Erickson RR
    J Biol Chem; 1969 Apr; 244(7):1729-40. PubMed ID: 5780838
    [No Abstract]   [Full Text] [Related]  

  • 13. ENZYMATIC N-HYDROXYLATION OF THE CARCINOGEN 2-ACETYLAMINOFLUORENE AND THE METABOLISM OF N-HYDROXY-2-ACETYLAMINOFLUORENE-9-14C IN VITRO.
    IRVING CC
    J Biol Chem; 1964 May; 239():1589-96. PubMed ID: 14193833
    [No Abstract]   [Full Text] [Related]  

  • 14. Protein biosynthesis in trypanosomidae. II. The metabolic fate of DL-leucine-1-C14 in Trypanosoma cruzi.
    Mancilla R; Naquira C; Lanas C
    Exp Parasitol; 1967 Oct; 21(2):154-9. PubMed ID: 6082615
    [No Abstract]   [Full Text] [Related]  

  • 15. Detection of metabolic carcinogen intermediates in urine of carcinogen-fed rats by means of bacterial mutagenesis.
    Commoner B; Vithayathil AJ; Henry JI
    Nature; 1974 Jun; 249(460):850-2. PubMed ID: 4209968
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenobarbital-mediated increase in ring- and N-hydroxylation of the carcinogen N-2-fluorenylacetamide, and decrease in amounts bound to liver deoxyribonucleic acid.
    Matsushima T; Grantham PH; Weisburger EK; Weisburger JH
    Biochem Pharmacol; 1972 Aug; 21(15):2043-51. PubMed ID: 4645881
    [No Abstract]   [Full Text] [Related]  

  • 17. Transport of carcinogens: rat blood plasma and red cell binding of isotope after N-hydroxy-N-2-fluorenylacetamide.
    Weisburger JH; Grantham PH; Weisburger EK
    Life Sci; 1966 Jan; 5(1):41-5. PubMed ID: 5933654
    [No Abstract]   [Full Text] [Related]  

  • 18. The puromycin reaction and its inhibition by chloramphenicol.
    Cannon M
    Eur J Biochem; 1968 Dec; 7(1):137-45. PubMed ID: 4884583
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of mitochondrial and bacterial protein synthesis by chloramphenicol.
    Freeman KB
    Can J Biochem; 1970 Apr; 48(4):479-85. PubMed ID: 4911451
    [No Abstract]   [Full Text] [Related]  

  • 20. Incorporation of amino acid into protein by utilizing a cell-free system from Paramecium.
    Reisner AH; Macindoe H
    J Gen Microbiol; 1967 Apr; 47(1):1-15. PubMed ID: 6034039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.